BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
BioRestorative Therapies, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026
$1.60+0.06 (+3.90%)
Close on Oct 19, 2026
- Market cap
- $28.36M
- P/E (TTM)
- –
- Dividend yield
- –
BioRestorative Therapies, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q1 17 | TTM Q4 16 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $311.87K | $300.00K | – | – | – | $300.00K | – | – | – | – | – | – | 87.1% | – |
| Royalty [Member] | $46.00K | $59.70K | $83.40K | $74.50K | $91.00K | $101.00K | $77.00K | $104.80K | $149.50K | $145.80K | – | – | 12.9% | -49.5% |
| Stem Pearls Skincare Products [Member] | – | – | – | – | – | – | – | – | – | – | $230 | $355 | – | – |
By region
From the segment and revenue-disaggregation notes of BioRestorative Therapies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.